Your browser doesn't support javascript.
loading
Phenotypic spectrum associated with PTCHD1 deletions and truncating mutations includes intellectual disability and autism spectrum disorder.
Chaudhry, A; Noor, A; Degagne, B; Baker, K; Bok, L A; Brady, A F; Chitayat, D; Chung, B H; Cytrynbaum, C; Dyment, D; Filges, I; Helm, B; Hutchison, H T; Jeng, L J B; Laumonnier, F; Marshall, C R; Menzel, M; Parkash, S; Parker, M J; Raymond, L F; Rideout, A L; Roberts, W; Rupps, R; Schanze, I; Schrander-Stumpel, C T R M; Speevak, M D; Stavropoulos, D J; Stevens, S J C; Thomas, E R A; Toutain, A; Vergano, S; Weksberg, R; Scherer, S W; Vincent, J B; Carter, M T.
Afiliação
  • Chaudhry A; Department of Pediatrics, Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Noor A; Department of Pathology and Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Degagne B; Molecular Neuropsychiatry and Development Lab, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Baker K; Molecular Neuropsychiatry and Development Lab, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Bok LA; Department of Medical Genetics, Cambridge, UK.
  • Brady AF; Institute for Medical Research Wellcome Trust, University of Cambridge, Cambridge, UK.
  • Chitayat D; Department of Clinical Genetics, Unit of Cytogenetics, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Chung BH; North West Thames Regional Genetics Service, Northwick Park Hospital, Harrow, UK.
  • Cytrynbaum C; Department of Pediatrics, Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Dyment D; The Prenatal Diagnosis and Medical Genetics Program, Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Filges I; Department of Pediatrics and Adolescent Medicine, Department of Obstetrics and Gynaecology, Centre for Reproduction, Development and Growth, Centre for Genomic Sciences, The University of Hong Kong, Pok Fu Lam, Hong Kong.
  • Helm B; Department of Pediatrics, Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Hutchison HT; Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Jeng LJ; Department of Genetics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
  • Laumonnier F; Division of Medical Genetics, Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
  • Marshall CR; Division of Medical Genetics and Metabolism, Children's Hospital of The King's Daughters/Eastern Virginia Medical School, Norfolk, VA, USA.
  • Menzel M; Departments of Neurology and Pediatrics, UCSF Fresno Medical Education Program, San Francisco, CA, USA.
  • Parkash S; Department of Laboratory Medicine, University of California, San Francisco, CA, USA.
  • Parker MJ; UMR_INSERM U930 Faculté de Médecine, Université François Rabelais, Tours, France.
  • Raymond LF; CeGaT GmbH, Tuebingen, Germany.
  • Rideout AL; Maritime Medical Genetics Service, IWK Health Centre, Halifax, Nova Scotia, Canada.
  • Roberts W; Dalhousie University Halifax, Nova Scotia, Canada.
  • Rupps R; Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Western Bank, Sheffield, UK.
  • Schrander-Stumpel CT; Department of Medical Genetics, Cambridge, UK.
  • Speevak MD; Institute for Medical Research Wellcome Trust, University of Cambridge, Cambridge, UK.
  • Stavropoulos DJ; Maritime Medical Genetics Service, IWK Health Centre, Halifax, Nova Scotia, Canada.
  • Stevens SJ; Autism Research Unit, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Thomas ER; Department of Medical Genetics, Children's and Women's Health Centre, University of British Columbia, Vancouver, BC, Canada.
  • Toutain A; Institute of Human Genetics, University Hospital Magedeburg, Magedeburg, Germany.
  • Vergano S; Department of Clinical Genetics and School for Oncology & Developmental Biology (GROW), Maastricht UMC+, Maastricht, The Netherlands.
  • Weksberg R; Credit Valley Site, Trillium Health Partners, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Onatario, Canada.
  • Scherer SW; Department of Pathology and Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Vincent JB; The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Carter MT; Department of Clinical Genetics and School for Oncology & Developmental Biology (GROW), Maastricht UMC+, Maastricht, The Netherlands.
Clin Genet ; 88(3): 224-33, 2015 Sep.
Article em En | MEDLINE | ID: mdl-25131214
ABSTRACT
Studies of genomic copy number variants (CNVs) have identified genes associated with autism spectrum disorder (ASD) and intellectual disability (ID) such as NRXN1, SHANK2, SHANK3 and PTCHD1. Deletions have been reported in PTCHD1 however there has been little information available regarding the clinical presentation of these individuals. Herein we present 23 individuals with PTCHD1 deletions or truncating mutations with detailed phenotypic descriptions. The results suggest that individuals with disruption of the PTCHD1 coding region may have subtle dysmorphic features including a long face, prominent forehead, puffy eyelids and a thin upper lip. They do not have a consistent pattern of associated congenital anomalies or growth abnormalities. They have mild to moderate global developmental delay, variable degrees of ID, and many have prominent behavioral issues. Over 40% of subjects have ASD or ASD-like behaviors. The only consistent neurological findings in our cohort are orofacial hypotonia and mild motor incoordination. Our findings suggest that hemizygous PTCHD1 loss of function causes an X-linked neurodevelopmental disorder with a strong propensity to autistic behaviors. Detailed neuropsychological studies are required to better define the cognitive and behavioral phenotype.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenótipo / Deleção de Sequência / Transtorno do Espectro Autista / Proteínas de Membrana / Deficiência Intelectual / Mutação Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Clin Genet Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenótipo / Deleção de Sequência / Transtorno do Espectro Autista / Proteínas de Membrana / Deficiência Intelectual / Mutação Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Clin Genet Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Canadá